RESTASIS
Live / Registered — Registered and renewed (as of 14 Feb 2023)
What this means for you
Registered since 15 Jul 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Jul 2023).
Record
- Serial number
- 78041554
- Registration number
- 2738873
- Mark type
- Word mark
- Filed
- 03 Jan 2001
- Published for opposition
- 21 Aug 2001
- Registered
- 15 Jul 2003
- Next maintenance due
- 15 Jul 2023
- Attorney of record
- Cheryl A. Withycombe
Goods and services
- Class 005 — Pharmaceuticals: Topical ophthalmic pharmaceutical products for the treatment of dryness of the eye
Owner
- Allergan, Inc., North Chicago, IL, US
- Allergan, Inc., Irvine, CA, US
- Allergan, Inc., Irvine, CA, US
Prosecution history
- 14 Feb 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Feb 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 14 Feb 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 13 Feb 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Jul 2022 — TEAS SECTION 8 & 9 RECEIVED
- 15 Jul 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Feb 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 22 Feb 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 22 Feb 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 22 Feb 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Feb 2013 — TEAS SECTION 8 & 9 RECEIVED
- 06 Feb 2013 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Aug 2008 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Aug 2008 — ASSIGNED TO PARALEGAL
- 12 Aug 2008 — TEAS SECTION 8 & 15 RECEIVED